Citation 71157

PETTIT,GR: GAO,F: DOUBEK,DL: BOYD,MR: HAMEL,E: BAI,R: SCHMIDT,JM: TACKETT,LP: RUTZLER,K:. (1993). ANTINEOPLASTIC AGENTS. CCLII. ISOLATION AND STRUCTURE OF HALISTATIN 2 FROM THE COMOROS MARINE SPONGE AXINELLA CARTERI.. 123(7)

Citation Details

Title	ANTINEOPLASTIC AGENTS. CCLII. ISOLATION AND STRUCTURE OF HALISTATIN 2 FROM THE COMOROS MARINE SPONGE AXINELLA CARTERI.
Authors	PETTIT,GR: GAO,F: DOUBEK,DL: BOYD,MR: HAMEL,E: BAI,R: SCHMIDT,JM: TACKETT,LP: RUTZLER,K:
Year	1993
Volume	123
Issue	7

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (2)

Axinella carteri (AXINELLIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HALISTATIN 2	None
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	STRONG ACTIVITY
4	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HALISTATIN 2	ACTIVE
5	TUBULIN BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HALISTATIN 2	ACTIVE
6	TUBULIN BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HALISTATIN 2	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	HALISTATIN 1	None
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HALICHONDRIN B	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALICHONDRIN B	STRONG ACTIVITY
10	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HALICHONDRIN B	ACTIVE
11	TUBULIN BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HALICHONDRIN B	ACTIVE
12	TUBULIN BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HALICHONDRIN B	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HALICHONDRIN B,HOMO:	None

Axinella species (AXINELLIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	HALISTATIN 2	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISTATIN 2	ACTIVE